Velacor Therapeutics' Other Investors

Velacor Therapeutics raised a round of funding on , . Investors include UniSeed.

Velacor is developing a treatment for prostate cancer through inhibition of the protein kinase Akt pathway. The technology will target the growing prostate cancer market, currently valued at $2.1 bill…

Articles about Velacor Therapeutics' Other Investors: